ASGE Interventional IBD: Management of Complications | March 2022-Diagnostic and Therapeutic Endoscopy for IBD during Pregnancy: Indication and Precautions

Diagnostic and Therapeutic Endoscopy for IBD during Pregnancy: Indication and Precautions

Video Transcription

Video Summary

The video features Dr. Susie Cain, a professor of medicine at Mayo Clinic Rochester, discussing the role of diagnosing therapeutic endoscopy fibro during pregnancy. Dr. Cain explains the FDA categories for medications used during endoscopy, which are no longer used formally but are still commonly referenced. She emphasizes the need for strong indications for endoscopy during pregnancy, such as significant GI bleeding or refractory symptoms. Dr. Cain provides guidelines for the safety of endoscopy during pregnancy, including the use of minimal sedation, positioning the patient to avoid compression of the vena cava or aorta, and the importance of consultation with an obstetrician. She also discusses the safety of various medications used during endoscopy, highlighting the importance of antibiotics such as ampicillin and gentamicin. Dr. Cain explains the limited data on the safety of endoscopy and colonoscopy in pregnant patients with inflammatory bowel disease (IBD), as well as the use of fecal calprotectin as a non-invasive marker of disease activity during pregnancy in IBD patients. Overall, Dr. Cain provides important insights and recommendations for the management of endoscopy in pregnant patients.<br /><br />No credits were granted in the video transcript.

Asset Subtitle

Sunanda V. Kane, MD, FASGE

Keywords

endoscopy

pregnancy

safety guidelines

medications

inflammatory bowel disease

management